Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,753–3,760 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Roivant Sciences Ltd. Brepocitinib Systemic lupus erythematosus (SLE) Phase 2b Trial Discontinued Oral Immunology
Roivant Sciences Ltd. Mosliciguat - (PHocus) Pulmonary hypertension associated with interstitial lung disease (PH-ILD) Phase 2 Enrollment Conclusion Oral Respiratory
Roivant Sciences Ltd. Cerdulatinib (DMVT-502) Vitiligo Phase 2 Trial Discontinued Oral N/A
Roivant Sciences Ltd. Namilumab - (RESOLVE-Lung) Sarcoidosis Phase 2 Trial Discontinued Intravenous infusion Respiratory
Roivant Sciences Ltd. Batoclimab Warm Autoimmune Hemolytic Anemia Phase 2 Trial Discontinued Intravenous Hematology
Royalty Pharma plc Zidesamtinib (NVL-520) - (ARROS-1) ROS1 Non-small cell lung cancer (NSCLC) PDUFA Data Released Oral Oncology
Royalty Pharma plc Aficamten (CK-274) - (MAPLE-HCM) Obstructive hypertrophic cardiomyopathy (HCM) Phase 3 Data Released Oral Cardiology
SAB Biotherapeutics Inc. SAB-185 COVID-19 Phase 3 Trial Completed Intravenous COVID-19